InvestorsHub Logo

jondoeuk

08/05/21 5:08 PM

#393960 RE: longfellow95 #393954

Yep, it's a dud.



Again, something we can agree on.

And it's an mRNA vaccine....
I wouldn't chance my arm on this one, personally speaking.



I will wait for the long-term data from them, MRNA, CVAC and others.

exwannabe

08/05/21 6:04 PM

#393967 RE: longfellow95 #393954

"Roche, BioNTech post 'low' response rate in cancer vaccine trial"


So when they report a low response rate it is a dud. But when NWBO reports a response rate of 0 it is just a bad metric.

Which is it?